ACH
Accendra Health Inc
0.708$
-3.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 68.4% | 71.1% | 72.2% | 64.6% | 67.3% | 66.1% | 64.0% | 65.7% | 42.6% | 41.3% | 43.4% | 22.3% | |
| 2.1% | 5.8% | 6.8% | 3.1% | 1.8% | 1.8% | 3.5% | 1.6% | 1.3% | 4.8% | 1.1% | 11.5% | |
| 2.1% | 5.8% | 6.8% | 3.1% | 1.8% | 1.8% | 3.5% | 1.6% | 1.3% | 4.8% | 1.1% | 11.5% | |
| 22.9% | 21.2% | 22.3% | 22.5% | 20.1% | 18.5% | 21.0% | 19.3% | 14.2% | 11.7% | 14.8% | 3.9% | |
| 31.9% | 33.9% | 33.7% | 29.3% | 34.2% | 31.5% | 37.0% | 42.3% | 24.8% | 21.8% | 24.3% | 3.0% | |
| – | – | – | – | – | – | – | – | 15.9% | 16.5% | 18.6% | 14.9% | |
| 15.5% | 15.1% | 15.3% | 21.1% | 11.0% | 10.8% | 11.8% | 11.0% | 30.4% | 32.2% | 28.6% | 50.1% | |
| 4.0% | 3.4% | 3.0% | 5.5% | 8.5% | 7.8% | 8.4% | 6.9% | 9.0% | 7.1% | 6.4% | 5.6% | |
| 63.8% | 64.3% | 64.7% | 69.9% | 86.3% | 87.3% | 78.7% | 73.5% | 82.4% | 81.9% | 87.9% | 118.8% | |
| 36.7% | 38.3% | 38.1% | 38.8% | 39.0% | 38.9% | 40.3% | 38.0% | 29.1% | 37.1% | 40.2% | 38.6% | |
| – | – | – | – | 0.8% | 2.3% | 1.0% | 1.2% | 1.8% | 5.7% | 1.0% | 12.0% | |
| 22.3% | 25.6% | 27.6% | 28.1% | 28.2% | 22.2% | 30.0% | 28.3% | 21.3% | 23.0% | 26.9% | 14.8% | |
| – | – | – | – | – | – | – | 26.8% | 46.1% | 37.1% | 38.6% | 73.4% | |
| 36.2% | 35.7% | 35.3% | 30.1% | 13.7% | 12.7% | 21.3% | 26.5% | 17.6% | 18.1% | 12.1% | -18.8% | |
| 25.1% | 25.4% | 25.2% | 20.5% | 5.3% | 3.8% | 5.0% | 11.0% | 7.6% | 7.2% | 0.1% | -44.0% | |
| 2.3% | 2.2% | 2.2% | 1.8% | 1.6% | 1.7% | 1.9% | 2.1% | 1.4% | 1.5% | 1.6% | 3.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.